Xconomy |
FDA Approves BioMarin Drug, A First for Rare Genetic Batten Disease
Xconomy BioMarin Pharmaceuticals has won the first FDA approval for a treatment for Batten disease, a rare group of disorders that rob children of vision, cognitive abilities, and motor skills, and usually prove deadly before adulthood. The San Rafael, CA ... FDA approves first treatment for a form of Batten disease Brineura Approved for Rare Genetic Illness Affecting Kids FDA approves new drug with a whopping $700000 price tag |
from Health - Google News http://ift.tt/2pdcpVb
EmoticonEmoticon